Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-MRI evaluation of chemotherapy with or without endostatin in bone metastatic NSCLC
ChiCTR-TRC-09000569Phase 4Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jul 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of endostar, vinorelbine and cisplatin in non-small cell lung cancer (NSCLC) and bone metastases (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Time to progression, Tumor blood flow by multi-MRI and 2 more. Started Jul 2009; status: completed.
02
Drugs
endostarvinorelbinecisplatin
03
Conditions
non-small cell lung cancer (NSCLC)bone metastases
Beyond the preview
Go deeper on ChiCTR-TRC-09000569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000569.